Ledger.Open graph →
SEC Form D · Amendment · filed June 13, 2025

AltrixBio, Inc

Offering
$6.6M
Sold
$6.6M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
WILMINGTON, DE
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (12)

Ali Tavakkoli · Lowell, MADirectorJeffrey Karp · Lowell, MADirectorJohn Brooks · Lowell, MADirectorNancy Briefs · Lowell, MAExec · DirectorJohn Brooks · Lowell, MADirectorNancy Briefs · Lowell, MAExec · DirectorAli Tavakkoli · Lowell, MADirectorJeffrey Karp · Lowell, MADirectorMark I. Andrews · NEW YORK, NYDirectorNaveen E. Balasubramanyam · Irving, TXDirectorJason E. Engelhorn · Irving, TXDirectorMichael J. Ambrosi · Clifton, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗